insights_auto
Why is GH down 3.54%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
$178.75
arrow_downward
-3.54%(-6.56) 1D
$178.80
arrow_upward
+0.03% (+0.050)bedtimeAfter hours
Closed: Oct 30, 3:53:50 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
$182.48
High
$185.64
Low
$175.44
Mkt. cap
23.99B
Avg. vol.
1.86M
Volume
1.06M
52-wk high
$191.01
52-wk low
$74.55
EPS
-$3.50
Beta
1.58
Shares outstanding
134.20M
No. of employees
2K
Open
$182.48
High
$185.64
Low
$175.44
Mkt. cap
23.99B
Avg. vol.
1.86M
Volume
1.06M
52-wk high
$191.01
52-wk low
$74.55
EPS
-$3.50
Beta
1.58
Shares outstanding
134.20M
No. of employees
2K
News stories
From web sources and news partners
Investing.com
·
20 hours ago
Guardant Health options signal 14% stock move on earnings
Zacks
·
1 day ago
Guardant Health (GH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Investing.com
·
3 days ago
BTIG raises Guardant Health stock price target on growth outlook
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2.5K
Founded2012
HeadquartersPalo Alto, California, United States
SectorHealth care provider
Websiteguardanthealth.com